AN

Amir Nashat

Polaris Partners

Cambridge, Massachusetts

VC
Investor

Invests in

  • Min Investment:

    $300,000.00

  • Max Investment:

    $2,000,000.00

  • Target Investment:

    $500,000.00

Education

Lists including Amir

AP
AO
AS
AN

Based in UK

1884 people

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14752 people

Investments

Matter Neuroscience

Seed

Total Funding: $26M

Freenome

Series A

Total Funding: $1.1B

Jnana Therapeutics

Series A

Total Funding: $160M

Scholar Rock

Series A

Total Funding: $310M

Dewpoint Therapeutics

Series A

Total Funding: $290M

Kojin Therapeutics

Series A

Total Funding: $60M

Primmune Therapeutics

Series A

Total Funding: $27M

1366 Technologies

Series B

Total Funding: $96M

AgBiome

Series A

Total Funding: $250M

Sofregen Medical

Series A

Total Funding: $6M

Work Experience

PS
Paratus Sciences

2023

  • Chief Executive Officer

    2023

CT
CAMP4 Therapeutics

2016

  • Board Member

    2016

DT
Dewpoint Therapeutics

2018

  • Board Member

    2018

  • Chief Executive Officer

    2018 - 2020

PP
Polaris Partners

2002

  • Managing Partner

    2002

    Polaris Partners has a 20-plus-year history of partnering with repeat entrepreneurs and world-class innovators who are improving the way we live and work.

  • Managing General Partner

    2002 - 2023

If
Institute for Protein Innovation

2017

  • Board Member

    2017

SR
Scholar Rock

2012

  • Board Member

    2012

MT
Morphic Therapeutic

2017

  • Board Member

    2017

A
AgBiome

2013

  • Board Member

    2013

MI
Metacrine, Inc.

2014 - 2023

  • Board Member

    2014 - 2023

SP
Syros Pharmaceuticals

2014 - 2022

  • Board Member

    2014 - 2022